A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : RGD

Search Conditions:
Search Keyword : RGD
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: RGD
Appearance Frequency: 356 time(s)
Long forms: 237

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
radiolabeled arginine-glycine-aspartic acid
(34 times)
Neoplasms
(5 times)
ECM (3 times)
FMDV (3 times)
FMD (2 times)
1988 Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
Rat Genome Database
(26 times)
Medical Informatics
(10 times)
QTL (4 times)
PW (2 times)
RS (2 times)
2002 Rat Genome Database (RGD): mapping disease onto the genome.
remitted geriatric depression
(13 times)
Psychiatry
(6 times)
aMCI (3 times)
ACE (2 times)
AD (2 times)
2008 Abnormal neural activity in the patients with remitted geriatric depression: a resting-state functional magnetic resonance imaging study.
Radiolabeled Arg-Gly-Asp
(12 times)
Nuclear Medicine
(4 times)
BBN (2 times)
PET (2 times)
SPECT (2 times)
2009 Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
radiophotoluminescent glass dosimeter
(7 times)
Biophysics
(4 times)
MC (2 times)
CBCT (1 time)
CT (1 time)
2013 [Dose distribution from kV-cone beam computed tomography in image-guided radiotherapy].
Rayleigh-Gans-Debye
(5 times)
Ophthalmology
(3 times)
FFF (1 time)
LD (1 time)
MAIS (1 time)
1979 Accuracy of RGD approximation for computing light scattering properties of diffusing and motile bacteria.
recognize the tripeptide Arg-Gly-Asp
(5 times)
Neoplasms
(2 times)
DOX (1 time)
ECM (1 time)
FAK (1 time)
2004 Protease-induced release of functional peptides from bioplexes.
RGD peptides
(5 times)
Biophysics
(1 time)
Coll (2 times)
ADMSCs (1 time)
BMP (1 time)
2007 Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling.
random gap detection
(4 times)
Occupational Medicine
(2 times)
FS (3 times)
DD (2 times)
HINT (2 times)
2007 Central auditory processing effects induced by solvent exposure.
10  68Ga-NODAGA-RGD and 68Ga-TRAP
(3 times)
Nuclear Medicine
(1 time)
--- 2013 Comparison of cyclic RGD peptides for alphavbeta3 integrin detection in a rat model of myocardial infarction.
11  receptors bind to the Arg-Gly-Asp
(3 times)
Virology
(1 time)
ALB (1 time)
Fg (1 time)
FMDV (1 time)
2000 Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
12  receptors via a highly conserved Arg-Gly-Asp
(3 times)
Biochemistry
(1 time)
beta2m (1 time)
CV-A9 (1 time)
FMDV (1 time)
1999 A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is required for binding to transferrin.
13  cyclic-RGD dimer, designated as c
(2 times)
Biology
(1 time)
RNAi (1 time)
siRNA (1 time)
siRNAs (1 time)
2017 Construction and Biological Evaluation of a Novel Integrin alphanubeta₃-Specific Carrier for Targeted siRNA Delivery In Vitro.
14  radiofrequency glow discharge
(2 times)
Dentistry
(2 times)
--- 1997 Effects of radiofrequency glow discharge on impression material surface wettability.
15  radiolabelled peptides based on the Arg-Gly-Asp
(2 times)
Biology
(1 time)
EDDA (1 time)
HYNIC (1 time)
2009 Radiolabelled RGD peptides and peptidomimetics for tumour targeting.
16  ratios of cell-binding peptide
(2 times)
Biomedical Engineering
(2 times)
FN (2 times)
PVAm (2 times)
ECM (1 time)
2003 Biometric surfactant polymers designed for shear-stable endothelialization on biomaterials.
17  recognizes adhesive proteins containing the Arg-Gly-Asp
(2 times)
Reproductive Medicine
(1 time)
GPIIb-IIIa (1 time)
1989 Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex.
18  recombinant peptide containing the Arg-Gly-Asp
(2 times)
Biochemistry
(1 time)
ABM (1 time)
FN (1 time)
NSCs (1 time)
2011 Microcarrier expansion of mouse embryonic stem cell-derived neural stem cells in stirred bioreactors.
19  red cells bearing arginine-glycine-aspartic acid
(2 times)
Drug Therapy
(1 time)
IPM (1 time)
IPMs (1 time)
2000 Platelet substitutes and novel platelet products.
20  residues, Arg-Gly-Asp
(2 times)
Molecular Biology
(1 time)
HUVE (1 time)
HYNIC (1 time)
rAvt-I (1 time)
2002 In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
21  RGD-containing peptide
(2 times)
Biomedical Engineering
(2 times)
AV (1 time)
Col (1 time)
PDA-PEO (1 time)
1998 Blood and tissue compatibility of modified polyester: thrombosis, inflammation, and healing.
22  Rhodostomin, an Arg-Gly-Asp
(2 times)
Neoplasms
(1 time)
ECM (1 time)
HUVEC (1 time)
mAb (1 time)
1995 The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
23  rich in arginyl-glycyl-aspartic acid
(2 times)
Chemistry
(1 time)
AP (1 time)
ASF (1 time)
HCT (1 time)
2014 Antheraea pernyi silk fibroin-coated PEI/DNA complexes for targeted gene delivery in HEK 293 and HCT 116 cells.
24  68Ga-NODAGA-RGD, and 4.1 0.7 for 68Ga-TRAP
(1 time)
Nuclear Medicine
(1 time)
--- 2013 Comparison of cyclic RGD peptides for alphavbeta3 integrin detection in a rat model of myocardial infarction.
25  Ad5GFP-R7-arginine-glycine-aspartic acid
(1 time)
Allergy and Immunology
(1 time)
Ad (1 time)
Ad5 (1 time)
FLS (1 time)
2005 Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
26  Arginine-Glycine-Aspartic acid-D-Phenylalanine-Lysine
(1 time)
Chemical Phenomena
(1 time)
NPs (1 time)
pCBMA (1 time)
PDPA (1 time)
2019 Antifouling and pH-Responsive Poly(Carboxybetaine)-Based Nanoparticles for Tumor Cell Targeting.
27  arginine-rich peptide with a terminal arginine-glycine-aspartic acid
(1 time)
General Surgery
(1 time)
CHF (1 time)
LV (1 time)
1997 Differential effects of novel protamine variants on myocyte contractile function with left ventricular failure.
28  AV-RSV-Lux could be effectively blocked by an arginine-glycine-asparagine
(1 time)
Genetics, Medical
(1 time)
AV (1 time)
1994 Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants.
29  beta8-integrin-regulated adhesion to Arg-Gly-Asp
(1 time)
Nephrology
(1 time)
Itgb8 (1 time)
LTGF (1 time)
PDGFBR (1 time)
2014 Mesangial cell alphavbeta8-integrin regulates glomerular capillary integrity and repair.
30  cys-RGD peptide
(1 time)
Dentistry
(1 time)
BG (1 time)
PEG (1 time)
2009 Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats.
31  cysteine-rich epidermal growth factor-like repeats and the sequence Arg-Gly-Asp
(1 time)
Genetics, Medical
(1 time)
--- 1989 Human nidogen: cDNA cloning, cellular expression, and mapping of the gene to chromosome Iq43.
32  disulfide-rich proteins containing an Arg-Gly-Asp
(1 time)
Metabolism
(1 time)
CTS (1 time)
ECM (1 time)
FBS (1 time)
1998 Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
33  EGR-1-regulated cells and was reversed by treatment with Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
FN (1 time)
PAI-1 (1 time)
TGF (1 time)
1999 The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1.
34  FL-RGD by covalently conjugating tumor marker cyclic arginine-glycine-aspartic acid tripeptide
(1 time)
Pharmacology
(1 time)
FACS (1 time)
PDT (1 time)
TADF (1 time)
2019 A dual-targeted theranostic photosensitizer based on a TADF fluorescein derivative.
35  four cyclo(Arg-Gly-Asp-D-Phe-Lys)
(1 time)
Chemistry
(1 time)
DTPA (1 time)
ETDA (1 time)
PBS (1 time)
2013 A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
36  Fru-RGD-chol ligand, where a fructose and peptide Arg-Gly-Asp
(1 time)
Chemistry
(1 time)
LIP (1 time)
TNBC (1 time)
2019 Dual-targeting liposomes with active recognition of GLUT5 and alphavbeta3 for triple-negative breast cancer.
37  gastrin-releasing peptide, arginine-glycine-aspartate
(1 time)
Nuclear Medicine
(1 time)
PRRT (1 time)
2010 Preclinical and clinical studies of peptide receptor radionuclide therapy.
38  HS-PEG-RGD
(1 time)
Nanotechnology
(1 time)
MG (1 time)
2013 'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities.
39  integrin-receptor-binding arginine-glycine-aspartic acid
(1 time)
Dentistry
(1 time)
BIC (1 time)
cys-PTH 1-34 (1 time)
PEG (1 time)
2010 Evaluation of parathyroid hormone bound to a synthetic matrix for guided bone regeneration around dental implants: a histomorphometric study in dogs.
40  integrin-recognition domain Arg-Gly-Asp
(1 time)
Drug Design
(1 time)
--- 2020 How not to discover a drug - integrins.
41  MAP-RGD, which is a recombinant MAP fused with an Arg-Gly-Asp
(1 time)
Biocompatible Materials
(1 time)
MAPs (1 time)
Ti-mesh (1 time)
2015 Bioengineered mussel glue incorporated with a cell recognition motif as an osteostimulating bone adhesive for titanium implants.
42  R-Gel based on human type I collagen has multiple Arg-Gly-Asp
(1 time)
Pharmacology
(1 time)
RCP (1 time)
2010 A new fluorescent imaging of renal inflammation with RCP.
43  radiochemistry development of PET tracers based on arginine-glycine-aspartic acid
(1 time)
Pharmacy
(1 time)
PET (1 time)
2013 RGD-based PET tracers for imaging receptor integrin alphav beta3 expression.
44  radiohalogenated Arg-Gly-Asp
(1 time)
Nuclear Medicine
(1 time)
LLC (1 time)
2006 Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
45  radiolabeled tracer based on a cyclic Arg-Gly-Asp
(1 time)
Therapeutics
(1 time)
--- 2014 Evaluation of alphanubeta3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.
46  Radiopharmaceuticals containing the motive tripeptide arginyl-glycyl-asparatic acid
(1 time)
Diagnostic Imaging
(1 time)
NOTA-RGD (1 time)
SPN (1 time)
2017 Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans.
47  radiopharmaceuticals currently under clinical investigation, such as integrin-binding arginine-glycine-aspartic acid
(1 time)
Biology
(1 time)
--- 2018 A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures.
48  radiosynthesis of clinical-grade (⁸F)FPP
(1 time)
Diagnostic Imaging
(1 time)
--- 2012 First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies.
49  radiotracers bound to arginine-glycine-aspartate
(1 time)
Nuclear Medicine
(1 time)
CLE (1 time)
SNR (1 time)
2014 Cerenkov luminescence endoscopy: improved molecular sensitivity with beta--emitting radiotracers.
50  Raman molecules and then conjugating arginine-glycine-aspartic acid
(1 time)
Biocompatible Materials
(1 time)
AA (1 time)
PPTT (1 time)
2019 Gold nanostars for cancer cell-targeted SERS-imaging and NIR light-triggered plasmonic photothermal therapy (PPTT) in the first and second biological windows.
51  random gene dissection
(1 time)
Biotechnology
(1 time)
--- 2005 Random gene dissection: a tool for the investigation of protein structural organization.
52  randomly generated data
(1 time)
Neurosciences
(1 time)
AP (1 time)
ME (1 time)
MN (1 time)
2014 Auditory category knowledge in experts and novices.
53  randomly oriented poly(vinyl alcohol) nano-fibrous scaffolds surface-modified with Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
PVA (1 time)
2013 Response of human mesenchymal stem cells to patterned and randomly oriented poly(vinyl alcohol) nano-fibrous scaffolds surface-modified with Arg-Gly-Asp (RGD) ligand.
54  range of decoupled and combined variations in integrin-binding peptide
(1 time)
Biomedical Engineering
(1 time)
ECM (1 time)
2020 Immobilized RGD concentration and proteolytic degradation synergistically enhance vascular sprouting within hydrogel scaffolds of varying modulus.
55  range of structures. alpha-Arginlyglycylaspartic acid
(1 time)
Bioengineering
(1 time)
--- 2018 beta3-tripeptides act as sticky ends to self-assemble into a bioscaffold.
56  range-gate depth
(1 time)
Ophthalmology
(1 time)
AO (1 time)
LGS (1 time)
2007 Optimizing Rayleigh laser guide star range-gate depth during initial loop closing.
57  ranging from nanometers to micrometers of the peptide arginine-glycine-aspartic acid
(1 time)
Biophysics
(1 time)
FAs (1 time)
VEGF (1 time)
2011 Spacing of integrin ligands influences signal transduction in endothelial cells.
58  rapid and efficient chemical synthesis of a cyclic Arg-Gly-Asp
(1 time)
Chemistry, Pharmaceutical
(1 time)
CADI (1 time)
2018 Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application.
59  rapid gas decompression
(1 time)
Polymers
(1 time)
CB (1 time)
HNBR (1 time)
2019 The Effect of the Surface Area of Carbon Black Grades on HNBR in Harsh Environments.
60  rare genetic disease
(1 time)
Genetics
(1 time)
--- 2020 New Diagnostic Approaches for Undiagnosed Rare Genetic Diseases.
61  RAS GTPase activating protein domain
(1 time)
Endocrinology
(1 time)
CSR (1 time)
NF1 (1 time)
2007 Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
62  Rat calvarial osteoblasts attached to Arg-Gly-Asp
(1 time)
Biomedical Engineering
(1 time)
AAm (2 times)
AA (1 time)
ECM (1 time)
1998 Biomolecular modification of p(AAm-co-EG/AA) IPNs supports osteoblast adhesion and phenotypic expression.
63  rat cardiac cells were seeded in Arginine-Glycine-Aspartate
(1 time)
Biotechnology
(1 time)
--- 2012 Effects of mechanical stimulation induced by compression and medium perfusion on cardiac tissue engineering.
64  rat cardiomyocytes were stimulated with a pentapeptide containing the Arg-Gly-Asp
(1 time)
Physiology
(1 time)
FAK (1 time)
L-NMMA (1 time)
NO (1 time)
2006 Integrin stimulation induces calcium signalling in rat cardiomyocytes by a NO-dependent mechanism.
65  rat His-OPN was adequately phosphorylated and contained a functional arginine-glycine-aspartate
(1 time)
Pathology
(1 time)
GFBP (1 time)
OPN (1 time)
rat His-OPN (1 time)
2005 Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin.
66  rates by electrohydrodynamic atomization, and arginyl-glycyl-aspartic acid
(1 time)
Biocompatible Materials
(1 time)
bFGF (1 time)
CAM (1 time)
HUVECs (1 time)
2019 Liquefied Microcapsules as Dual-Microcarriers for 3D+3D Bottom-Up Tissue Engineering.
67  rating of gait disturbance
(1 time)
Occupational Health
(1 time)
PRT (1 time)
2020 Assessment of risk of tripping before and after crossing obstacles under dimmed lighting conditions.
68  ratios of peptides including the tripeptide arginine-glycine-aspartic acid
(1 time)
Biomedical Engineering
(1 time)
PLGA (1 time)
2001 Effect of RGD coating on osteocompatibility of PLGA-polymer disks in a rat tibial wound.
69  react to bond the cell-adhesive peptide arginine-glycine-aspartic acid
(1 time)
Chemistry
(1 time)
--- 2007 High-yield activation of scaffold polymer surfaces to attach cell adhesion molecules.
70  react with mixtures of an adhesion-promoting peptide containing Arg-Gly-Asp
(1 time)
Biomedical Engineering
(1 time)
hTCEpi (1 time)
2012 Functionalization of reactive polymer multilayers with RGD and an antifouling motif: RGD density provides control over human corneal epithelial cell-substrate interactions.
71  reacted with thiol-containing peptide
(1 time)
Biochemistry
(1 time)
hMSCs (1 time)
PEG (1 time)
2010 Injectable Biodegradable Poly(ethylene glycol)/RGD Peptide Hybrid Hydrogels for in vitro Chondrogenesis of Human Mesenchymal Stem Cells.
72  reactions could be used to obtain arginylglycylaspartic acid
(1 time)
DOX (1 time)
Dox-LNC (1 time)
2017 Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells.
73  reactive granulomatous dermatitis
(1 time)
Dermatology
(1 time)
--- 2020 Clinical and histologic presentation of pediatric reactive granulomatous dermatitis.
74  reactive green dye
(1 time)
Environmental Health
(1 time)
PGP (1 time)
2019 Reactive green dye remediation by Alternanthera philoxeroides in association with plant growth promoting Klebsiella sp. VITAJ23: A pot culture study.
75  reasoned that in hen egg white lysozyme the tripeptide L-arginyl-glycyl-aspartate
(1 time)
Biochemistry
(1 time)
--- 1993 Modulation of actin polymerization by an exogenous protein, lysozyme.
76  REC Graphlet Degree
(1 time)
Medicine
(1 time)
GRN (1 time)
REC (1 time)
TFs (1 time)
2016 Graphlet Based Metrics for the Comparison of Gene Regulatory Networks.
77  received TP-9201, an Arginine-Glycine-Aspartic acid
(1 time)
Cardiology
(1 time)
APTT (1 time)
GP (1 time)
rt-PA (1 time)
1996 Pharmacokinetics and pharmacodynamics of TP-9201, a gpIIbIIIa antagonist, administered in combination with recombinant tissue-type plasminogen activator, heparin, and aspirin in beagles.
78  recently been suggested that the Arg-Gly-Asp sequence
(1 time)
Science
(1 time)
--- 1987 Peptides containing the cell-attachment recognition signal Arg-Gly-Asp prevent gastrulation in Drosophila embryos.
79  recently developed a series of new Arg-Gly-Asp
(1 time)
Molecular Biology
(1 time)
MTD (1 time)
2011 Two ⁹⁰Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy.
80  recently disclosed the discovery of a tripeptide Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
--- 2007 R-isomers of Arg-Gly-Asp (RGD) mimics as potent alphavbeta3 inhibitors.
81  Recently, salmosin, a novel snake venom-derived disintegrin containing the Arg-Gly-Asp
(1 time)
Neoplasms
(1 time)
BCE (1 time)
CAM (1 time)
HEK (1 time)
2004 Inhibition of angiogenesis by salmosin expressed in vitro.
82  receptor antagonist, generated using the tripeptide Arg-Gly-Asp
(1 time)
Pharmacology
(1 time)
HAEC (1 time)
HUVEC (1 time)
2014 Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells.
83  receptor binding based on its functional arginine-glycine-aspartic acid
(1 time)
Virology
(1 time)
ELISA (1 time)
HPeV (1 time)
2012 Prokaryote expression of HPeV-1 VP1 protein, production of VP1 polyclonal antibody and the development of an ELISA.
84  receptor binding domain of fibronectin
(1 time)
Urology
(1 time)
--- 1992 In vitro particulate adherence to fibronectin: correlation with in vivo particulate adherence to sites of bladder injury.
85  receptor bound only to fibronectin of the various Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
--- 1989 Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor.
86  receptor GP IIb/IIIa with adhesive fibrinogen sequence Arg-Pro-Asp
(1 time)
Physiology
(1 time)
--- 1999 [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
87  receptor specific ligand molecules arginine-glycine-aspartic acid
(1 time)
GO (1 time)
QD (1 time)
RGD-MAP-C (1 time)
2015 Neural Cell Chip Based Electrochemical Detection of Nanotoxicity.
88  receptor specificity of novel peptide-dye conjugate arginine-glycine-aspartic acid
(1 time)
Neoplasms
(1 time)
--- 2004 In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
89  receptor that has ligand binding specificity for the Arg-Gly-Asp
(1 time)
Cell Biology
(1 time)
--- 1989 A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis.
90  receptor was conferred by incorporating an arginine-glycine-aspartic acid
(1 time)
Genetics, Medical
(1 time)
CRAds (1 time)
OPG (1 time)
sOPG (1 time)
2010 Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer.
91  receptor-binding motif arginine-glycine aspartic acid
(1 time)
Microbiology
(1 time)
HPeVs (1 time)
2019 Highly sensitive parechovirus CODEHOP PCR amplification of the complete VP1 gene for typing directly from clinical specimens and correct typing based on phylogenetic clustering.
92  receptor-binding peptides, a dicarba analogue of octreotide and the Arg-Gly-Asp
(1 time)
Chemistry
(1 time)
--- 2011 Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex.
93  receptor-guided design
(1 time)
Chemistry
(1 time)
--- 2019 A Receptor-Guided Design Strategy for Ligand Identification.
94  receptor-ligand binding of an arginine-glycine-aspartic acid
(1 time)
Nuclear Medicine
(1 time)
PET (1 time)
ROI (1 time)
2011 Quantification of receptor-ligand binding with [⁸F]fluciclatide in metastatic breast cancer patients.
95  receptors bind ligands containing the Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
--- 1997 Identification of a region in the integrin beta3 subunit that confers ligand binding specificity.
96  receptors expressed on inflammatory cells through its arginine-glycine-aspartate
(1 time)
Toxicology
(1 time)
HCC (1 time)
OPN (1 time)
2008 Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
97  receptors following their interaction with surface-immobilized Arg-Gly-Asp
(1 time)
Biomedical Engineering
(1 time)
EGF (1 time)
FA (1 time)
2012 Regulation of integrin adhesions by varying the density of substrate-bound epidermal growth factor.
98  receptors via a highly conserved arginine-glycine-aspartic acid
(1 time)
Virology
(1 time)
FMDV (1 time)
2003 Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.
99  receptors were blocked in normal platelets by the tripeptide Arg-Gly-Asp
(1 time)
Biochemistry
(1 time)
PAI-1 (2 times)
ADP (1 time)
GP (1 time)
1994 Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
100  receptors, such as integrin, to adhesive motifs, such as Arg-Gly-Asp
(1 time)
Nanotechnology
(1 time)
SPION (1 time)
2017 Remote Control of Multimodal Nanoscale Ligand Oscillations Regulates Stem Cell Adhesion and Differentiation.